Loss of E-cadherin is associated with acquisition of metastatic capacity. Numerous studies suggest that histone deacetylation and/or hypermethylation of CpG islands in E-cadherin gene (CDH1) are major mechanisms responsible for E-cadherin silencing in different tumors and cancer cell lines. The hepatitis B virus (HBV)-encoded X antigen, HBx, contributes importantly to the development of hepatocellular carcinoma using multiple mechanisms. Experiments were designed to test if in addition to CDH1 hypermethylation HBx promotes epigenetic modulation of E-cadherin transcriptional activity through histone deacetylation and miR-373. The relationships between HBx, E-cadherin, mSin3A, Snail-1 and miR-373 were evaluated in HBx expressing (HepG2X) and control (HepG2CAT) cells by western blotting, immunoprecipitation (IP), chromatin IP as well as by immunohistochemical staining of liver and tumor tissue sections from HBVinfected patients. In HepG2X cells, decreased levels of E-cadherin and elevated levels of mSin3A and Snail-1 were detected. Reciprocal IP with anti-HBx and anti-mSin3A demonstrated mutual binding. Furthermore, HBx-mSin3A colocalization was detected by immunofluorescent staining. HBx downregulated E-cadherin expression by the recruitment of the mSin3A/histone deacetylase complex to the Snail-binding sites in human CDH1. Histone deacetylation inhibition by Trichostatin-A treatment restored E-cadherin expression. Mir-373, a positive regulator of E-cadherin expression, was downregulated by HBx in HepG2X cells and tissue sections from HBV-infected patients. Thus, histone deacetylation of CDH1 and downregulation of miR-373, together with the previously demonstrated hypermethylation of CDH1 by HBx, may be important for the understanding of HBV-related carcinogenesis.
Introduction
The transmembrane glycoprotein E-cadherin provides a physical link between adjacent cells and is crucial for cell polarity and the structural integrity of tissue (van Roy and Berx, 2008) . In addition, it is a component of the cellular signaling network (Takeichi, 1991) . Altered expression and cellular distribution of E-cadherin is frequently associated with dedifferentiation and invasiveness in human cancers, including hepatocellular carcinoma (HCC; Endo et al., 2000; Hirohashi and Kanai, 2003) . Loss of E-cadherin is also a critical feature of intrahepatic metastasis in HCC (Osada et al., 1996) . Frequent (67%) CpG methylation of CDH1 (E-cadherin gene) correlated with reduced E-cadherin expression in both primary HCCs and liver tissues of patients with chronic liver disease (Kanai et al., 1997) .
Hepatitis B virus (HBV) is a major etiologic agent of chronic liver disease and HCC. The virally encoded X antigen (HBx) contributes importantly to the development of HCC through multiple mechanisms in diverse subcellular compartments, ranging from the nucleus (Weil et al., 1999) to the cytoplasm (Sirma et al., 1998) and mitochondria (Waris et al., 2001) . Cytoplasmic HBx may influence the regulation of gene expression through different signal-transduction pathways (Kekule et al., 1993) , while nuclear HBx directly affects transcriptional machinery (Nomura et al., 1999) , including epigenetic modulation (Park et al., 2007) . In this context, HBx has been shown to suppress E-cadherin at both the mRNA and protein levels by inducing the activities of the DNA-methyltransferases (DNMT) DNMT1 and DNMT3A and by promoting methylation of CDH1 (Lee et al., 2005; Park et al., 2007) .
Recently, another epigenetic mechanism was described that represses transcription of the E-cadherin gene; the zinc-finger transcription factor Snail binds to the E-boxes of the CDH1 promoter (Giroldi et al., 1997) and recruits a transcriptional repressor complex containing mSin3A/HDAC (Peinado et al., 2004) . Inhibition of Snail in epithelial cancer cell lines lacking E-cadherin restored the expression of CDH1 (Batlle et al., 2000) . Moreover, there is a strong inverse correlation between the Snail and E-cadherin in various carcinomas, such as breast, pancreas, colon and HCC (Jiao et al., 2002; Sugimachi et al., 2003) . Snail has been found overexpressed in the cells located at the invasive front of tumors (Guarino et al., 2007) , promoting tumor invasiveness. Snail genes are activated by most pathways triggering epithelial-to-mesenchymal transition . Such pathological activation of Snail and repression of E-cadherin were observed during fibrosis and tumor progression (Moustakas and Heldin, 2007) . HCC is characterized by high levels of histone deacetylase 1 (HDAC1; Rikimaru et al., 2007) . HBx was shown to upregulate HDAC1, resulting in increased angiogenesis and inhibition of apoptosis (Yoo et al., 2008) . In addition, HBx recruitment of HDAC1 repressed insulinlike growth factor-binding protein 3 transcription (Shon et al., 2009) . As HBx-HDAC1 (Shon et al., 2009; Zheng et al., 2009) and Snail-HDAC1/2-mSin3A (Peinado et al., 2004) interactions have been demonstrated, it is possible that HBx may also interact with mSin3A, and recruit this complex to CDH1 to repress E-cadherin. This may provide an additional epigenetic mechanism of E-cadherin repression, by which HBx contributes to pathogenesis of chronic liver disease and HCC.
Prior work has shown that altered expression of specific micro RNAs (miRNAs) is involved in tumorigenesis (Agami, 2010 ). miRNA(s) regulate gene expression by repressing translation or directing sequence-specific degradation of mRNA. However, RNA duplexes mediate transcriptional activation through the targeting of complementary motifs in gene promoters, such as those of E-cadherin, p21
WAF1/CIP1 and vascular endothelial growth factor Janowski et al., 2007) . In this regard, transfection of miR-373 and its precursor hairpin RNA (pre-miR-373) into PC-3 cells induced E-cadherin expression (Place et al., 2008) . The roles of miR-373, as well as Snail-HDAC1/2-mSin3A, in the regulation of CDH1 expression in pathogenesis of HBx-associated hepatocarcinogenesis, have not been explored. The results from this study show that these molecules may also be operative, underscoring the importance of suppressed CDH1 expression in liver cancer, and that HBx is central to triggering these changes.
Results
Relationships between HBx, E-cadherin, mSin3A and Snail-1 in vitro Initial experiments were performed to determine whether HBx altered the expression of E-cadherin, mSin3A and/or Snail-1 in cultured liver cells. Accordingly, whole-cell lysates from HepG2X and HepG2CAT cells were analyzed by western blotting. There was a 3.8±0.3-fold decrease in the levels of E-cadherin in HepG2X compared with control cells (Figure 1a) , as shown previously . Similar results were observed in Hep3BX compared with Hep3BCAT cells . In HepG2X nuclear cell extracts, there was upregulation of mSin3A (2.5 ± 1.1-fold) and Snail-1 (2.0±0.7-fold; Figure 1b ). When HBx was introduced into the primary human hepatocytes, E-cadherin was downregulated 1.1 ± 0.5-fold or 24% (Po0.03) 4 days later (Figures 1c and d) . These data show that HBx suppresses E-cadherin and stimulates the expression of mSin3A and Snail-1.
Relationship between HBx, E-cadherin, mSin3A and Snail-1 in vivo Clinical samples containing HCC and nontumor liver were stained for HBx, E-cadherin, mSin3A and Snail-1. Among 42 patients who underwent surgical resection for HBV-associated HCC, 30 had both tumor and adjacent nontumor liver, 9 had only tumor in their blocks and 3 patients had only nontumor liver. Among these, HBx staining was observed in 27 of 39 tumors (69%) and in all 33 nontumor livers (100%) (Supplementary Table 1 ). In 82% of cases with tumor and nontumor tissues, HBx staining was stronger and more widespread in liver compared with tumor, as previously reported . Commercially available liver sections from 10 uninfected individuals were negative for HBx. HBx staining was cytoplasmic in all cases (Figure 2a ; Wang et al., 1991b) . Nuclear HBx staining was also observed (Supplementary Figure S1) , as shown earlier (Wang et al., 1991a) . For E-cadherin, membranous staining was detected in 10 of 39 tumors (26%), in 21 of 33 cases where nontumor liver was available (64%; Supplementary Table 1 ) and in uninfected controls (Supplementary Figure S2) . These results are similar to those previously published . Nuclear mSin3A staining was observed in the nontumor liver from 19 of 33 patients (58%; Supplementary Table 1, Figure 2a ) and 
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A Arzumanyan et al in 20 of 39 tumors (51%; Figure 2b , Supplementary Figure S3 ). mSin3A and Snail-1 staining in uninfected liver was undetectable (Figures 2b and c) . With regard to Snail-1, staining was observed in the nontumor compartment from 17 of 33 patients (52%) (Figure 2a ) and in the tumor compartment from 22 of 39 patients (56%; Supplementary Table 1, Figure 2c , and Supplementary Figure S3 ). Hence, mSin3A and Snail upregulation was observed in HBV-associated HCC. Additional analyses were conducted to determine the relationship between HBx and these markers. An inverse correlation was seen between HBx and E-cadherin in 21 cases of nontumor (Po0.025). As expected, there was no correlation between HBx and E-cadherin in the Figure 2 Representative staining for (a) HBx, Snail-1, mSin3A and E-cadherin in consecutive sections from a block of a patient with HBV-infected liver ( Â 400). Representative staining for mSin3A (b) and Snail-1 (c) from uninfected human liver (top photo in b and c) and from a block of HCC (bottom photo in b and c) ( Â 400).
Repression of E-cadherin by hepatitis B virus x antigen A Arzumanyan et al tumor compartment, with costaining in only seven cases (P40.95). HBx and mSin3A were significantly associated in nontumor liver (Po0.005), but not in HCC (P40.75). Similarly, HBx and Snail-1 were significantly associated in nontumor liver (Po0.005), but not in tumor (P40.7). This is not surprising in light of the fact that HBx staining was stronger and widespread in liver tissue compared with most HCC nodules in the same patients (Wang et al., 1991a) . Therefore, if HBx promotes upregulation of mSin3A and Snail-1, this would be observed most readily in liver tissue surrounding tumor nodules. In addition, upregulated mSin3A and Snail-1 were observed in both nontumor liver (Po0.001) and in tumor (Po0.001). This is expected, as it is known that Snail-1 binds to mSin3A (MacPherson et al., 2010) . Given that Snail and mSin3A make up part of a complex that represses E-cadherin expression (Peinado et al., 2004) , the finding of no significant relationships between the expression of E-cadherin with mSin3A or Snail-1 is consistent with their expected roles in the suppression of E-cadherin in vivo.
Interaction between HBx and mSin3A
The tissue staining results above suggest that HBx may suppress E-cadherin expression, in part, by altering the E-cadherin suppressor complex containing mSin3A. To determine whether HBx physically interacts with mSin3A, reciprocal immunoprecipitation (IP) experiments were performed with HepG2X and HepG2CAT cell lysates. Prior work showed that HBx is present in both the cell cytoplasm (Sirma et al., 1998) and nucleus (Weil et al., 1999) . As mSin3A is a nuclear protein, it was first important to verify that HBx was detectable in nuclear extracts. The latter was shown by western blotting with anti-HBx ( Figure 3a , lane 1). IP with anti-mSin3A showed HBx in cell lysates from HepG2X, but not in HepG2CAT cells ( Figure 3a , lanes 2 and 3, respectively). 
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Reciprocal IP with anti-HBx, followed by western blotting with anti-mSin3A showed strong reactivity with mSin3A in HepG2X, but not in HepG2CAT cells ( Figure 3b , lanes 1 and 2), suggesting physical association between mSin3A and HBx. To confirm the subcellular localization where this association occurs, HepG2X cells were stained with anti-HBx (red staining in Figure 3c ), anti-mSin3A (green staining in Figure 3d ) and 4,6-diamidino-2-phenylindole (blue staining in Figure 3e ). When the images were merged, HBxmSin3A colocalization was observed in the nuclei of HepG2X cells as small orange regions ( Figure 3f ). These staining results were analogous to those observed in tissue sections from infected patients (for example, in Figure 2 ), and support the hypothesis of HBx-mSin3A nuclear colocalization.
HBx recruits mSin3A to the E-cadherin promoter HBx was shown to recruit DMNTs to suppress E-cadherin expression (Park et al., 2007; Zheng et al., 2009) . Thus, chromatin immunoprecipitation assays were performed to determine whether HBx recruits the mSin3A/HDAC complex, which is known to suppress E-cadherin (Peinado et al., 2004) . In this context, the human CDH1 contains three regulatory elements consisting of a CANNTG (called 'E-boxes') located in the proximal promoter and in exon 1 (Giroldi et al., 1997) .
As Snail mediates E-cadherin repression by the recruitment of the mSin3A/HDAC1 complex to the E-boxes (Peinado et al., 2004) , experiments were designed to target this fragment (which included all three E-boxes) for PCR amplification following chromatin immunoprecipitation ( Figure 4a ). Chromatin immunoprecipitation assays showed increased levels of mSin3A and HDAC1, but decreased levels of Acetyl-H3 and RNA polymerase II at the regions of the Snail-binding sites in HBx-expressing cells compared with control ( Figure 4b ).
To verify the functional importance of this finding, HepG2X and HepG2CAT cells were treated with the HDAC inhibitor, Trichostatin A (TSA). HDAC inhibition by TSA treatment restored H3 acetylation and Ecadherin expression ( Figure 4c ). As HBx can directly interact with HDAC (Shon et al., 2009; Zheng et al., 2009) and with mSin3A (Figure 3 ), these results confirm that HBx mediates CDH1 deacetylation by recruiting the mSin3A/HDAC complex.
HBx downregulates miR-373
MicroRNAs contribute importantly to the pathogenesis of many tumor types (Agami, 2010 Figure 5a and  Supplementary Table 2) , and an average of 4.5-fold change in the remaining 5 patients. HBx suppressed miR-373 in nontumor compared with tumor by an average of 21-fold. When looking at the relationships between HBx, miR-373 and histopathology, there was a strong correlation of HBx with chronic hepatitis (Po0.02) and cirrhosis (Po0.01), as expected (Wang et al., 1991a, b) . HBx expression in liver inversely correlated with the levels of miR-373 in the same compartment (Po0.005), and the same relationship was also seen in HCC (Po0.05). Importantly, suppressed miR-373 in nontumor correlated with Edmondson grade III-IV (Po0.005) and with venous invasion (Po0.001), suggesting that suppressed miR-373 in liver was associated with more aggressive tumors.
To further validate that E-cadherin is targeted by miR-373, HepG2X cells were transiently transfected with hsa-miR-373 precursor and levels of E-cadherin were measured by western blotting (Figure 5b ). As expected, in the presence of miR-373, E-cadherin was upregulated (threefold, Po0.015). Together, these results indicate that miR-373 may be a target of HBx both in human liver and cell lines.
Discussion
There are roughly 350 million carriers of HBV worldwide at risk for chronic liver disease and HCC. Chronic HBV infection underlies up to 80% of HCC cases (Park et al., 2006) . The HBV-encoded HBx protein contributes importantly to HCC, although the associated mechanisms are not clear. HBx is localized in the cytoplasm (Sirma et al., 1998) , mitochondria (Waris et al., 2001) and the nucleus (Nomura et al., 1999) . Thus, HBx may exert effects upon pathogenesis in different subcellular compartments (Keasler et al., 2009) . For example, cytoplasmic HBx may regulate gene expression through signal-transduction pathways that affect the control of the cell cycle, proliferation or apoptosis (Lupberger and Hildt, 2007 ). An association of HBx with the outer membrane of mitochondria induces oxidative stress (Waris et al., 2001 ), while nuclear HBx may exert transcription factor-like functions (Haviv et al., 1996) . Epigenetic modulation of transcriptional activity of the target genes could be an important mechanism for HBxmediated transformation, as HBx does not bind to DNA. In agreement with this suggestion, HBx was shown to elevate the overall intracellular activities of DNMT1, DNMT3A1 and DNMT3A2, selectively promote hypermethylation of tumor suppressor genes (such as GSTP1 and CDKN2B; Park et al., 2007) and, 
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A Arzumanyan et al importantly, CDH1 (Lee et al., 2005; Zheng et al., 2009) . Previous work showed E-cadherin suppression in HBxpositive cells and human liver tissue sections at both the protein and mRNA levels. This was associated with hypermethylation of CpG islands in CDH1 . Moreover, depressed E-cadherin correlated with HBx trans-activation, and expression of E-cadherin was restored by treatment with the DNMT inhibitor 5 0 -Aza-2 0 dC (Lee et al., 2005) . In this study, HBx was also shown to suppress E-cadherin expression via recruitment of the mSin3A/HDAC complex to CDH1 ( Figures  3 and 4) and by suppression of miR-373 ( Figure 5 , Supplementary Table 2 ), indicating that additional mechanisms target suppression of E-cadherin in chronic hepatitis B.
The main adhesion molecule of epithelia, E-cadherin, maintains cells in a stationary, nonmotile state (van Roy and Berx, 2008) . Abnormalities in the expression and cellular distribution of E-cadherin are frequently associated with dedifferentiation, invasiveness and poor prognosis in a variety of human malignancies, including HCC (Endo et al., 2000) . Re-establishing the functional E-cadherin complex in tumor cell lines resulted in a reversion from an invasive to a benign epithelial phenotype (Perl et al., 1998) . Downregulation of E-cadherin induces epithelial-to-mesenchymal transition that is characterized by acquisition of a motile mesenchymal phenotype. As a result, cells detach and disseminate to distant sites (Iwatsuki et al., 2009) . The finding that HBx promotes the migration of liver cells, and that this is associated with downregulated expression of E-cadherin , underscores the importance of suppressed CDH1 to HBV-associated HCC.
Another cellular mechanism that triggers chromatin remodeling is histone deacetylation, which yields a more compact chromatin structure, and represses gene transcription by limiting the accessibility of transcription factors to target genes (Ropero and Esteller, 2007) . The transcription factor Snail-1 has been described as a direct repressor of E-cadherin through interaction with the CDH1 promoter region and recruitment of mSin3A/ HDAC deacetylase activity (Peinado et al., 2004) . The analyses of biopsies obtained from HCC confirmed that Snail-1 expression correlates with the decreased levels of E-cadherin and with dedifferentiation and invasiveness (Sugimachi et al., 2003) . Recent studies revealed HDAC1 as a direct HBx-interacting partner (Shon et al., 2009; Zheng et al., 2009) , thus raising the question as to whether HBx is associated with other members of this epigenetic complex. The finding that HBx interacts with mSin3A in vitro (Figure 3 ), and correlates with both mSin3A and Snail-1 in vivo (Figure 2 , Supplementary Table 1 ), supports this hypothesis. An important characteristic of the interaction between DNA methylation and HDAC activity, particularly in maintaining the aberrant silencing of hypermethylated genes in cancer, is that the methylation seems to function as the dominant event that seals transcriptional repression: histone deacetylation is secondary to DNA methylation (Cameron et al., 1999) . Interestingly, the inhibition of histone deacetylation by the HDAC inhibitor TSA could induce hyperacetylation of histones and restore the expression of methylated E-cadherin (Ou et al., 2007) . Thus, methylation and deacetylation could function together to potentiate the repressed state of E-cadherin. In fact, it was shown that methyl-CpGbinding protein 2 recruits mSin3a/HDAC to the methylated CDH1 promoter, leading to histone-3 deacetylation (Takeno et al., 2004) . In this context, it is documented that HBx promotes both hypermethylation of CDH1 and histone deacetylation through recruitment of the mSin3A/HDAC complex to CDH1 (Figure 4) . Furthermore, it is expected that these mechanisms are also operative with regard to other HBx target genes in hepatocarcinogenesis.
Cancer development has also been linked to alterations in miRNA expression through the silencing of target genes (He and Hannon, 2004; Agami, 2010) . However, miRNAs may function as transcription factors targeting complementary motifs in promoter regions to positively regulate gene expression (Place et al., 2008) . In this regard, miR-373 was shown to induce E-cadherin expression by binding to a target site in the CDH1 promoter. Transfection of miR-373 and its precursor hairpin RNA (pre-miR-373) into PC-3 cells induced E-cadherin expression (Place et al., 2008) . In this study, there was an inverse relationship between HBx and miR-373 both in vitro and in vivo (Figures 1  and 5, Supplementary Table 2 ), suggesting that miRNA epigenetic control of CDH1 (and perhaps other) gene expression is also regulated by HBx. Depressed miR-373 in nontumor cells also correlated with the presence of undifferentiated tumors with venous invasion, which is characteristic of aggressive HCC. The latter may indicate that in tumor cells, which often lack HBx, restoration of miR-373 expression may promote tumorigenesis. In addition to HBx, restoration of miR-373 in tumors may be due to other factors that remain to be deciphered.
In addition to the mechanisms above, HBx may also suppress CDH1 by activation of transforming growth factor-b (TGFb). TGFb activates Snail expression through the extracellular signal-regulated protein kinase and phosphatidylinositol 3 0 -kinase pathways and/or through phosphorylation of SMADs that, upon nuclear translocation, trigger Snail expression (Peinado et al., 2003) . Interestingly, extracellular signal-regulated protein kinase, phosphatidylinositol 3 0 -kinase and selected SMADs are also activated by HBx (Lee et al., 2001; Chung et al., 2004) . HBx, in turn, directly promotes TGFb expression through trans-activation (Yoo et al., 1996) , by stimulating Smad4 (which mediates TGFb signaling; Lee et al., 2001) and by reducing expression of the major TGFb inhibitor a2-macroglobulin (Pan et al., 2004) . Thus, HBx, through activation of TGFb, may potentially upregulate Snail and downregulate E-cadherin. These pathways will be explored in the future. Together, the findings herein emphasize the role of the HBx as a central factor in HBV-induced epigenetic alterations that contribute to the pathogenesis of HCC.
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Materials and methods

Cell culture
The human hepatoblastoma cell line, HepG2, was stably transfected with HBx (HepG2X) or the bacterial chloramphenicol acetyltransferase (control) gene (HepG2CAT) and maintained in culture as previously described (Lian et al., 1999) . Primary human hepatocytes were purchased from ZenBio (Research Triangle Park, NC, USA) and cultured in medium provided by the manufacturer.
Patient samples
Formalin fixed, paraffin-embedded paired tumor (HCC)/ nontumor (adjacent liver) tissues were obtained from 42 Chinese patients who underwent surgery at the Third Military Medical University, Chongqing, China. All were positive for hepatitis B surface antigen in blood, 40 were males, the age range was from 36 to 69 (average: 48) years, and all were of Chinese ethnicity. Additional snap-frozen tumor/nontumor pairs from 19 HBV-infected Chinese patients were obtained from Queen Mary College, University of Hong Kong, China. All patients were positive for hepatitis B surface antigen in blood, 18 were male and their age ranged from 33 to 71 years (average: 51). Ten uninfected human liver tissues (Abcam, Cambridge, MA, USA) were used as controls. All samples were used for diagnostic purposes, and then for this study. The use of these samples was approved by the Institutional Review Boards at all participating universities.
Protein extraction and western blotting
Cells were lysed in cell lysis buffer with protease inhibitor cocktail (Cell Signaling, Danvers, MA, USA). Nuclear extracts were prepared using a Nuclear Extract Kit (Active Motif, Carlsbad, CA, USA) according to enclosed instructions. Protein extracts were separated by SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes (Schleicher & Schuell, Sanford, ME, USA). The membranes were incubated overnight in 5% nonfat milk in Tris-buffered saline/0.1% Tween-20 with primary antibodies against HBx, E-cadherin, Snail-1, lamin A, b-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), mSin3a (Abcam) and Ac-Lys H3 (Active Motif). The blots were developed using the ECL plus detection kit (Amersham, Piscataway, NJ, USA) and exposed to Kodak imaging films (Rochester, NY, USA). Signal intensities were quantified using ImageJ software (NIH, Bethesda, MD, USA).
Introduction of HBx into human hepatocytes
Five million primary human hepatocytes were treated with 8 mg/ml of cell-penetrating recombinant protein, 11R-HBx (LD BioPharma, San Diego, CA, USA), and 2.5 mM of fusogenic peptide TAT-HA2 to stabilize 11R-HBx from macropinocytosis (Wadia et al., 2004) twice per day for 4 days. 11R-based recombinant peptides were previously used in a similar protocol for the generation of induced pluripotent stem cells (Zhou et al., 2009) . TAT-H2 was synthesized at the Peptide Synthesis core facility, Temple University. Cells were lysed and analyzed by western blotting. This experiment was reproduced with three different batches of human hepatocytes.
Treatment of cells with TSA Suspensions of 3.5 Â 10 5 cells were plated in 35-mm culture dishes with or without 350 nM TSA (Sigma, St Louis, MO, USA) in 2 ml of medium. Extracts were collected at 12 and 24 h and analyzed by western blotting.
Immunohistochemistry
Tissue sections were deparaffinized, dehydrated, treated with Uni-TRIEVE antigen retrieval (Innovex, Richmond, CA, USA) and stained using the UltraVision Detection System (Thermo Scientific, Rockford, IL, USA) according to the enclosed instructions. Antibodies used for staining were the same as those described for western blotting, except for antiHBx (anti-99 peptide antibody; Feitelson et al., 1988) and antimSin3A (Santa Cruz Biotechnology). Normal mouse or rabbit immunoglobin-G (Vector Labs, Burlingame, CA, USA) were used to rule out false-positive responses. Preabsorption of primary antibodies with corresponding antigens, and staining liver sections from uninfected individuals, were performed on tissue sections to insure specificity.
Immunoprecipitation
Protein extracts (500 mg) were incubated with anti-HBx (Santa Cruz Biotechnology) or anti-mSin3a (Abcam) and protein-G sepharose beads (GE Healthcare, Uppsala, Sweden) in HNTG buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 10% glycerol and protease inhibitor cocktail (Cell Signaling, Danvers, MA, USA)) overnight at 4 1C. The immunoprecipitates were washed with HNTG buffer, resolved by SDS-polyacrylamide gel electrophoresis and visualized by immunoblotting with antibodies against HBx or mSin3a, as described in western blotting protocol.
Chromatin immunoprecipitation assay
HepG2X and HepG2CAT cells were crosslinked with 1% formaldehyde for 20 min at room temperature. Prior to formaldehyde crosslinking, cells were treated for 20 min with 10 mM dimethyl adipimidate (Sigma), a protein-to-protein crosslinking agent for the proteins that bind indirectly to DNA (Zeng et al., 2006) . The crosslinking reaction was quenched with 50 mM glycine-phosphate-buffered saline for 10 min. Cells were washed with phosphate-buffered saline, dounce homogenized in hypotonic buffer (Active Motif) and centrifuged 10 min at 5000 r.p.m. The pellet was resuspended in a buffer consisting of 50mM HEPES, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS and protease inhibitor cocktail. Sonication was done in a Branson Sonifier SLP (Branson Ultrasonic, Danbury, CT, USA) at 80% power. The sheared samples were centrifuged for 15 min at 13 000 r.p.m. Anti-mSin3A (Abcam), anti-Ac-H3, anti-HDAC1, RNA polymerase II (all from Millipore, Billerica, MA, USA), immunoglobin G (negative control) and protein-G Sepharose beads (GE Healthcare) were used for IP. The samples were washed, resuspended in the elution buffer (1% SDS, 50 mM NaHCO 3 ), and reverse crosslinked. DNA was extracted with phenol-chloroform. PCR amplification was carried out with PCR Master Mix (Promega, Madison, WI, USA) for 25-33 cycles consisting of 30 s at 95 1C, 30 s at 58 1C and 60 s at 72 1C. The primers for the CDH1 were as follows: (F) 5 0 -TAGAGGGTCACCGCGTCTAT-3 0 and (R) 5 0 -GGGCTGGAGTCTGAACTGA-3 0 . Ready positive control primers (Ambion, Austin, TX, USA) amplify a 361-bp fragment, which is a highly conserved region of a constitutively expressed 'housekeeping' gene, rig/S15. The synthesized fragments were separated on 2% agarose gel and visualized with ethidium bromide.
Immunofluorescence microscopy HepG2X and HepG2CAT cells were fixed with ice-cold ethanol/acetic acid (95:5, vol/vol) and incubated with antiHBx and anti-mSin3a (Santa Cruz Biotechnology). Fluorescein isothiocyanate-and rhodamine-conjugated secondary antibodies were from Santa Cruz Biotechnology. Sections were washed, mounted in Vectashield aqueous mounting medium with 4,6-diamidino-2-phenylindole (Vector Labs), and analyzed using an ECLIPSE Ti inverted microscope, fitted with a Nikon DS-Fi1 camera and containing NIS Elements software (Nikon, Melville, NY, USA).
MicroRNA analysis
Small RNAs were isolated from HepG2X and HepG2CAT cells and 19 pairs of HCC tissue samples using Ambion mirVana miRNA isolation kit (Ambion), according to the enclosed instructions. MicroRNA array analysis was performed by LC Sciences (Houston, TX, USA). Differentially expressed miRNAs were identified by Cy3(HepG2X)/Cy5(-HepG2CAT) ratio, and those with Po0.01 were considered for further characterization. Differential expression of selected miRNAs was validated by quantitative reverse transcription-PCR using miScript SYBR Green PCR Kit (Qiagen, Valencia, CA, USA) and a Mastercycler realplex system (Eppendorf, Humburg, Germany). The DDC t calculation was done as follows: DDC t ¼ DC t of miR-373 in tumorÀDC t of miR-373 in nontumor tissue. Briefly, samples were first reverse transcribed, and quantitative PCR was performed using miScript PCR Kit RNA as follows: 15 min at 95 1C, and 40 cycles (94 1C for 15 s and 70 1C for 30 s). U6 was used for normalization. hsa-miR-373 and U6 were from Qiagen.
Transient transfection of HepG2X cells with 100 nm hsamiR-373 precursor was performed using DharmaFECT 1 (Dharmacon, Lafayette, CO, USA), according to the enclosed instructions. Experiments were carried out in triplicate.
Statistics
The relationships between HBx and E-cadherin, mSin3A and Snail-1 obtained by immunohistochemistry, as well as relationships between HBx, miR-373 and tissue histopathology, were determined using 2 Â 2 comparisons in the w 2 -test. Statistical significance was considered when Po0.05. Student's t-test was performed to compare paired samples from western blotting and PCR.
